Order Article Reprints

Khreish F, Wiessner M, Rosar F, Ghazal Z, Sabet A, Maus S, Linxweiler J, Bartholomä M, Ezziddin S. Response Assessment and Prediction of Progression-Free Survival by ⁶⁸Ga-PSMA-11 PET/CT Based on Tumor-to-Liver Ratio (TLR) in Patients with mCRPC Undergoing ¹⁷⁷Lu-PSMA-617 Radioligand Therapy. Biomolecules. 2021; 11(8):1099. https://doi.org/10.3390/biom11081099

Khreish, Fadi, Mona Wiessner, Florian Rosar, Zaidoon Ghazal, Amir Sabet, Stephan Maus, Johannes Linxweiler, Mark Bartholomä, and Samer Ezziddin. 2021. "Response Assessment and Prediction of Progression-Free Survival by ⁶⁸Ga-PSMA-11 PET/CT Based on Tumor-to-Liver Ratio (TLR) in Patients with mCRPC Undergoing ¹⁷⁷Lu-PSMA-617 Radioligand Therapy" Biomolecules 11, no. 8: 1099. https://doi.org/10.3390/biom11081099

Khreish, F., Wiessner, M., Rosar, F., Ghazal, Z., Sabet, A., Maus, S., Linxweiler, J., Bartholomä, M., & Ezziddin, S. (2021). Response Assessment and Prediction of Progression-Free Survival by ⁶⁸Ga-PSMA-11 PET/CT Based on Tumor-to-Liver Ratio (TLR) in Patients with mCRPC Undergoing ¹⁷⁷Lu-PSMA-617 Radioligand Therapy. Biomolecules, 11(8), 1099. https://doi.org/10.3390/biom11081099